Skip to content

fix: exclude datanews to prevent pubDate error (/caixin/latest)#8068

Merged
DIYgod merged 3 commits intoDIYgod:masterfrom
tpnonthealps:caixin_fix_220821
Nov 27, 2021
Merged

fix: exclude datanews to prevent pubDate error (/caixin/latest)#8068
DIYgod merged 3 commits intoDIYgod:masterfrom
tpnonthealps:caixin_fix_220821

Conversation

@tpnonthealps
Copy link
Copy Markdown
Contributor

@tpnonthealps tpnonthealps commented Aug 22, 2021

该 PR 相关 Issue / Involved issue

Close #

完整路由地址 / Example for the proposed route(s)

/caixin/latest

新RSS检查列表 / New RSS Script Checklist

  • New Route
  • Documentation
    • CN
    • EN
  • 全文获取 fulltext
    • Use Cache
  • 反爬/频率限制 anti-bot or rate limit?
    • 如果有, 是否有对应的措施? If yes, do your code reflect this sign?
  • 日期和时间 date and time
    • 可以解析 Parsed
    • 时区调整 Correct TimeZone
  • 添加了新的包 New package added
  • Puppeteer

说明 / Note

@vercel
Copy link
Copy Markdown

vercel bot commented Aug 22, 2021

This pull request is being automatically deployed with Vercel (learn more).
To see the status of your deployment, click below or on the icon next to each commit.

🔍 Inspect: https://vercel.com/diy/rsshub/7A95tMzt42CFa5FKETVx9TZEje52
✅ Preview: https://rsshub-git-fork-tpnonthealps-caixinfix220821-diy.vercel.app

@github-actions
Copy link
Copy Markdown
Contributor

Successfully generated as following:

https://rsshub-mhf18wora-diy.vercel.app/caixin/latest - Success
    <?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"

>
    <channel>
        <title><![CDATA[财新网 - 最新文章]]></title>
        <link>http://www.caixin.com/</link>
        <atom:link href="https://rsshub-mhf18wora-diy.vercel.app/caixin/latest" rel="self" type="application/rss+xml" />
        <description><![CDATA[财新网 - 最新文章 - Made with love by RSSHub(https://github.com/DIYgod/RSSHub)]]></description>
        <generator>RSSHub</generator>
        <webMaster>[email protected] (DIYgod)</webMaster>
        
        
        
        <language>zh-cn</language>
        
        <lastBuildDate>Sun, 22 Aug 2021 08:48:47 GMT</lastBuildDate>
        <ttl>5</ttl>
        
        <item>
            <title><![CDATA[华北制药“始乱终弃” 集采断供有多严重?]]></title>
            <description><![CDATA[<blockquote><p>国家“带量采购”的低价集采药品断供或供应不及时频现,华北制药为首个违规受罚案例</p></blockquote><img src="https://img.caixin.com/2021-08-22/1629619756396982_480_320.jpg" alt="华北制药是第三批国家组织药品集中采购品种布洛芬缓释胶囊的中选企业。据上海阳光医药采购网披露,其在山东省未能按协议供应约定采购量,相关部门多次约谈协商,供应情况仍未改善,企业于8月11日自行提出放弃中选资格。行情由财新数据提供" referrerpolicy="no-referrer">
       <p>  <b>【财新网】(记者 刘登辉 滑昂)</b>“共和国医药长子”<a href="https://s.ccxe.com.cn/entities/companies/200000825" target="_blank">华北制药</a>(600812.SH)供货不足后主动放弃集采中选资格。作为警告,医保局取消其9个月内参与国家集采的资格。截至发稿,华北制药方面尚未针对此事做出回应,但断供风波在行业已引发不少讨论。</p>
<p>  华北制药是第三批国家组织药品集中采购品种布洛芬缓释胶囊的中选企业。据上海阳光医药采购网披露,其在山东省未能按协议供应约定采购量,相关部门多次约谈协商,供应情况仍未改善,企业于8月11日自行提出放弃中选资格。国家组织药品联合采购办公室成员单位集体审议后,将其列入“违规名单”,取消华北制药自2021年8月11日至2022年5月10日参与国采的申报资格。</p>
      ]]></description>
            <pubDate>Sun, 22 Aug 2021 08:03:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.caixin.com/2021-08-22/101758453.html</guid>
            <link>http://www.caixin.com/2021-08-22/101758453.html</link>
            
            

@github-actions
Copy link
Copy Markdown
Contributor

Successfully generated as following:

https://rsshub-boiwow2e3-diy.vercel.app/caixin/latest - Success
    <?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"

>
    <channel>
        <title><![CDATA[财新网 - 最新文章]]></title>
        <link>http://www.caixin.com/</link>
        <atom:link href="https://rsshub-boiwow2e3-diy.vercel.app/caixin/latest" rel="self" type="application/rss+xml" />
        <description><![CDATA[财新网 - 最新文章 - Made with love by RSSHub(https://github.com/DIYgod/RSSHub)]]></description>
        <generator>RSSHub</generator>
        <webMaster>[email protected] (DIYgod)</webMaster>
        
        
        
        <language>zh-cn</language>
        
        <lastBuildDate>Sun, 22 Aug 2021 09:23:41 GMT</lastBuildDate>
        <ttl>5</ttl>
        
        <item>
            <title><![CDATA[华北制药挨罚 “带量采购”中选后断供有多严重?]]></title>
            <description><![CDATA[<blockquote><p>国家“带量采购”的低价集采药品断供或供应不及时频现,华北制药为首个违规受罚案例</p></blockquote><img src="https://img.caixin.com/2021-08-22/1629619756396982_480_320.jpg" alt="华北制药是第三批国家组织药品集中采购品种布洛芬缓释胶囊的中选企业。据上海阳光医药采购网披露,其在山东省未能按协议供应约定采购量,相关部门多次约谈协商,供应情况仍未改善,企业于8月11日自行提出放弃中选资格。行情由财新数据提供" referrerpolicy="no-referrer">
       <p>  <b>【财新网】(记者 刘登辉 滑昂)</b>“共和国医药长子”<a href="https://s.ccxe.com.cn/entities/companies/200000825" target="_blank">华北制药</a>(600812.SH)供货不足后主动放弃集采中选资格。作为警告,医保局取消其9个月内参与国家集采的资格。截至发稿,华北制药方面尚未针对此事做出回应,但断供风波在行业已引发不少讨论。</p>
<p>  华北制药是第三批国家组织药品集中采购品种布洛芬缓释胶囊的中选企业。据上海阳光医药采购网披露,其在山东省未能按协议供应约定采购量,相关部门多次约谈协商,供应情况仍未改善,企业于8月11日自行提出放弃中选资格。国家组织药品联合采购办公室成员单位集体审议后,将其列入“违规名单”,取消华北制药自2021年8月11日至2022年5月10日参与国采的申报资格。</p>
      ]]></description>
            <pubDate>Sun, 22 Aug 2021 08:03:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.caixin.com/2021-08-22/101758453.html</guid>
            <link>http://www.caixin.com/2021-08-22/101758453.html</link>
            
            

@github-actions
Copy link
Copy Markdown
Contributor

Successfully generated as following:

https://rsshub-2npcj8h6i-diy.vercel.app/caixin/latest - Success
    <?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"

>
    <channel>
        <title><![CDATA[财新网 - 最新文章]]></title>
        <link>http://www.caixin.com/</link>
        <atom:link href="https://rsshub-2npcj8h6i-diy.vercel.app/caixin/latest" rel="self" type="application/rss+xml" />
        <description><![CDATA[财新网 - 最新文章 - Made with love by RSSHub(https://github.com/DIYgod/RSSHub)]]></description>
        <generator>RSSHub</generator>
        <webMaster>[email protected] (DIYgod)</webMaster>
        
        
        
        <language>zh-cn</language>
        
        <lastBuildDate>Mon, 23 Aug 2021 23:07:15 GMT</lastBuildDate>
        <ttl>5</ttl>
        
        <item>
            <title><![CDATA[骨科关节国采9月14日天津开标 国产化不足三成]]></title>
            <description><![CDATA[<blockquote><p>骨科关节国家组织带量采购涉及厂家、产品众多,规则复杂,有招采人士形容其为高值医用耗材集采难度之最。由于集采规则较为温和,此前头部国产企业股价曾暴涨</p></blockquote><img src="https://img.caixin.com/2021-08-23/1629728073052883_480_320.jpg" alt="此前,地方集采中已对骨科植入产品作出大量探索。2020年8月,安徽省骨科集采关节类240个产品平均降幅81.97%。江苏省集采中,初次置换人工膝关节平均降幅67.3%,最大降幅81.9%。资料图:医生为患者做膝关节单髁置换术。图/IC PHOTO" referrerpolicy="no-referrer">
       <p>  <b>【财新网】(记者 刘登辉)</b>第二批高值医用耗材国家组织带量采购即将开标,8月23日晚,据天津市医药采购中心官网发布的人工关节集中带量采购方案,人工髋关节、人工膝关节集采将于9月14日在天津开标。此次开标前,联采办还将在8月26日召开企业培训会。此次集采涉及厂家及产品众多,规则复杂,有招采人士形容其为高值医用耗材集采难度之最,披露的招采文件就达384页。</p>
<p>  此前,骨科关节集采已有预热。今年4月1日,国家组织高值医用耗材联合采购办公室开始对人工髋关节、人工膝关节类产品信息采集。6月曾披露集采消息,但未公布意向采购量比例、最高有效申报价、集采开标时间等细节。由于集采规则较为温和,当时头部企业<a href="https://s.ccxe.com.cn/entities/companies/201727650" target="_blank">爱康医疗</a>(01789.HK)、<a href="https://s.ccxe.com.cn/entities/companies/200399864" target="_blank">春立医疗</a>(01858.HK)、<a href="https://s.ccxe.com.cn/entities/companies/200264585" target="_blank">微创医疗</a>(00853.HK)、<a href="https://s.ccxe.com.cn/entities/companies/200060674" target="_blank">威高股份</a>(01066.HK)等股价暴涨。</p>
      ]]></description>
            <pubDate>Mon, 23 Aug 2021 14:05:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.caixin.com/2021-08-23/101758957.html</guid>
            <link>http://www.caixin.com/2021-08-23/101758957.html</link>
            
            

@DIYgod DIYgod merged commit e0d44f2 into DIYgod:master Nov 27, 2021
auto-bot-ty added a commit to auto-bot-ty/RSSHub that referenced this pull request Nov 27, 2021
* docs: update sponsor

* feat: add hotukdeals

* feat: hotukdeals radar

* feat: add PS5 stock UK - The Independent

* fix(route): allow preLoginFlow of instagram to fail (DIYgod#8340)

Based on discussion in instragram-private-api repo, we do not need
this function for login.

See:
dilame/instagram-private-api#1411
dilame/instagram-private-api#1417

* style: auto format

* feat: pixiv PIXIV_IMG_PROXY

* fix: douban guid

* feat(route): add Research Gate Publications (DIYgod#7544)

* feat(route): add QuestMobile行业研究报告 (DIYgod#7552)

* chore: remove no-return-await eslint rule

* feat(route): add RSS3 Blog (DIYgod#7566)

Co-authored-by: DIYgod <[email protected]>

* style: auto format

* feat(route): add Odaily星球日报活动 (DIYgod#7666)

* feat: remove toutiao

* chore: format

* feat(route): add fashion network news (DIYgod#7602)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add dbaplus社群活动 (DIYgod#7584)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add 德阳考试中心 (DIYgod#7901)

* feat(route): add 央视网栏目 (DIYgod#7937)

Co-authored-by: DIYgod <[email protected]>

* style: auto format

* fix: infzm timezone (DIYgod#7695)

* fix: undefined error when no magnet & torrent (DIYgod#7745)

* feat(route): add World Health Organization News (DIYgod#8022)

Co-authored-by: DIYgod <[email protected]>

* fix: exclude datanews to prevent `pubDate` error (`/caixin/latest`) (DIYgod#8068)

* feat(route): add World Health Organization Speeches (DIYgod#8048)

Co-authored-by: DIYgod <[email protected]>

* Fix AP News article's title (DIYgod#8086)

* feat(route): add Now 熱門新聞 (DIYgod#8093)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add Uwants (DIYgod#8094)

Co-authored-by: DIYgod <[email protected]>

* fix: lazyloadRouteHandler

* fix: add Lofter话题/标签文章分类 & 视频 (DIYgod#8054)

* feat(route): add yunnan normal university (DIYgod#8097)

* feat(route): add 香港討論區 (DIYgod#8101)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add 香港高登 (DIYgod#8109)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add 华南理工大学教务处学院通知 (DIYgod#8110)

* fix(route): incorrect source links in yuzu emulator (DIYgod#8111)

* fix(route): migrate initium routes to new timezone (DIYgod#8124)

* feat(route): add yahoo japan covid19 news collection 日本疫情消息汇总 (DIYgod#8099)

* feat(route): add Asian to lick (DIYgod#8156)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* feat(route): add "micmicidol" (DIYgod#8070)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* feat(route):add 拷贝漫画 (DIYgod#7896)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* feat(route): add SBS中文 (DIYgod#8149)

Co-authored-by: DIYgod <[email protected]>

* feat(route): add Netflix Newsroom (DIYgod#8135)

Co-authored-by: SettingDust <[email protected]>
Co-authored-by: NeverBehave <[email protected]>
Co-authored-by: DIYgod <[email protected]>

* fix(route): 修正北京教育考试院内容提取错误 (DIYgod#8209)

* fix(route): dekudeals error due to ad (DIYgod#8214)

* feat(route): add 旺球体育直播间 (DIYgod#8276)

Co-authored-by: DIYgod <[email protected]>

* fix(route): 深圳证券交易所最新规则 (DIYgod#8284)

* feat(route): add 人民网领导留言板 (DIYgod#8285)

* feat(router): timednews 时刻新闻 (DIYgod#8279)

Co-authored-by: Tony <[email protected]>

* feat(router): ccac 澳门廉政公署 (DIYgod#8273)

Co-authored-by: Tony <[email protected]>

* add 安全文摘 (DIYgod#8294)

Co-authored-by: testkaili <[email protected]>
Co-authored-by: kaiili <[email protected]>

* feat(router): cebbank 光大银行 (DIYgod#8293)

* feat(route): add NGOCN (DIYgod#8301)

Co-authored-by: DIYgod <[email protected]>

* chore: format

* feat(route): add IT之家专题 (DIYgod#8312)

* feat(route)(v2): add 旅法师营地首页 (DIYgod#8350)

* feat(route): add 辛華社 (DIYgod#8357)

* feat(route): add Literotica Category (DIYgod#8415)

* feat(route): add Literotica News Stories (DIYgod#8410)

Co-authored-by: DIYgod <[email protected]>

* misc: add NOROUTE instruction back to template (DIYgod#8379)

Co-authored-by: Sukka <[email protected]>

* feat(route): jandan use the origin gif instead the thumbs (DIYgod#8406)

* feat(route): add HKJunkCall資訊中心 (DIYgod#8405)

* fix(route): fix furstar pic href (DIYgod#8404)

* feat(route): add ScienceDirect Journal (DIYgod#8399)

* feat(route): add Harvard Business Review Topic (DIYgod#8395)

* fix(route)(hket): migrate to v2 (DIYgod#8132)

* chore: format

Co-authored-by: DIYgod <[email protected]>
Co-authored-by: Shizun Ge <[email protected]>
Co-authored-by: GitHub Action <[email protected]>
Co-authored-by: Ethan Shen <[email protected]>
Co-authored-by: DIYgod <[email protected]>
Co-authored-by: zytomorrow <[email protected]>
Co-authored-by: Sean Chao <[email protected]>
Co-authored-by: junfengP <[email protected]>
Co-authored-by: Toby Tso <[email protected]>
Co-authored-by: ninboy <[email protected]>
Co-authored-by: SettingDust <[email protected]>
Co-authored-by: Rongrong <[email protected]>
Co-authored-by: coxde <[email protected]>
Co-authored-by: sgqy <[email protected]>
Co-authored-by: KotoriK <[email protected]>
Co-authored-by: btdwv <[email protected]>
Co-authored-by: NeverBehave <[email protected]>
Co-authored-by: erriy <[email protected]>
Co-authored-by: Kevin Carter <[email protected]>
Co-authored-by: linbuxiao <[email protected]>
Co-authored-by: Tony <[email protected]>
Co-authored-by: kaiili <[email protected]>
Co-authored-by: testkaili <[email protected]>
Co-authored-by: kaiili <[email protected]>
Co-authored-by: auto-bot-ty <[email protected]>
Co-authored-by: Yishuai Li <[email protected]>
Co-authored-by: Sukka <[email protected]>
Co-authored-by: Oddcc <[email protected]>
Co-authored-by: tuzi3040 <[email protected]>
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment

Projects

None yet

Development

Successfully merging this pull request may close these issues.

3 participants